Health Security

We are a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in health security.

Leader in Public-Private Partnerships

We have proven relationships with key health security constituencies in the U.S. government.

Our Lead Product, TPOXX®

TPOXX would play a critical role in responding to a smallpox bioterror attack.

Our Pipeline

Attractive product and market expansion opportunities

Our Team

Experienced team of scientists and business leaders

Our Partners

Rich history of successful partnerships to support our vision

SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX®

Learn More

News & Press Releases

More News

Health Security is a $10 billion market

Medical countermeasures for biological, chemical, radiological and nuclear attacks, as well as vaccines, therapeutics and diagnostics for emerging infectious diseases

  • Corporate Headquarters
    31 East 62nd Street
    New York, NY 10065
    (212) 672-9100

  • SIGA Development Operations
    4575 SW Research Way, Suite 110
    Corvallis, OR 97333
    (541) 753-2000

HCP and Product Inquiries: Call 541-766-3744